Kym F. Faull, PhD
Professor and Laboratory Director
Google Scholar, PubMed, or CV
Kym Francis Faull was educated at the University of Adelaide, South Australia (Bachelor of Agricultural Science, 1968, Honors degree in Agricultural Biochemistry (nitrogen metabolism of soil-borne bacteria), 1969 and a Ph.D. degree in Plant Physiology in 1974 (gibberellin biosynthesis)). After a post-doctoral fellowship (74-76) at the University of Wollongong, New South Wales (human metabolic diseases), he joined the research staff at Stanford University School of Medicine Department of Psychiatry and Behavioral Sciences (76-90) where he rose through the ranks. He joined the faculty at UCLA in 1990 and is now Professor in the Department of Psychiatry & Biobehavioral Sciences. His publication record reflects a background in biochemistry and experience in the characterization and quantitation of biomolecules by mass spectrometry. This includes experience with metabolic screening using gas chromatography-mass spectrometry for organic acidurias and other inherited diseases, work on biogenic amines and related compounds in the major neuropsychiatric illnesses (major depressive disorder, schizophrenia, etc), and since joining the UCLA faculty work on a wide range of projects from basic biochemistry to archaeology.
Julian P. Whitelegge, PhD
ResearchGate, LinkedIn, Google Scholar, PubMed, or career highlights
Professor Whitelegge’s research and teaching are focused on the application of biological mass spectrometry to the study of structure/function relationships of integral membrane proteins, understanding protein misfolding and the relationship to neurodegenerative disease, elucidating radiation insult and mitigation biomarkers, exploring inter-relationships of metabolism and molecular mechanisms of diabetes, as well as other systems biology projects in peptidomics, lipidomics and proteomics.
Andrew Norris, PhD
Dr. Norris has experience in discovery and preclinical drug development. Current area of focus is in the development of small molecule modulators of tissue damage from ionizing radiation in both the normal and cancer setting.
Piotr Ruchala, PhD
Associate Project Scientist
Peter received his PhD in organic chemistry from University of Wroclaw (Poland) working on asymmetric synthesis of amino acids and peptide synthesis. From 2002 he worked at UPenn, Harvard, Stanford and now UCLA, developing various peptide-based therapeutics. He recently joined the Pasarow Mass Spectrometry Laboratory at the Semel Institute and is involved in investigations of the pharmacokinetic of various compounds, with emphasis on those that show promise as radiation insult mitigation biomarkers.
Elizabeth Singer, PhD
Associate Project Scientist
I am using Mass Spectrometry and Proteomics to look for protein biomarkers for radiation exposure. These could be used for clinical purposes such as optimizing radiation therapy for cancer patients. This might lessen the side effects of radiation therapy like nausea, lung damage and neurologic problems.
Austin graduated from UCLA in 2012 with a BSc in Biochemistry and again in 2018 with a PhD in Human Genetics. He is currently a postdoctoral scholar with research interests in high-dimensional biology (genomics, proteomics, metabolomics), bioinformatics, computational biology, and machine learning.
Whitaker graduated from UC Santa Barbara in 2013 with a BS in Biopsychology. He is currently working as a research assistant, focusing bottom-up proteomics. He is responsible for operation and maintenance of Thermo LTQ Orbitrap XL instruments.